1
|
Richardson SAC, Anderson D, Burrell AJC, Byrne T, Coull J, Diehl A, Gantner D, Hoffman K, Hooper A, Hopkins S, Ihle J, Joyce P, Le Guen M, Mahony E, McGloughlin S, Nehme Z, Nickson CP, Nixon P, Orosz J, Riley B, Sheldrake J, Stub D, Thornton M, Udy A, Pellegrino V, Bernard S. Pre-hospital ECPR in an Australian metropolitan setting: a single-arm feasibility assessment-The CPR, pre-hospital ECPR and early reperfusion (CHEER3) study. Scand J Trauma Resusc Emerg Med 2023; 31:100. [PMID: 38093335 PMCID: PMC10717258 DOI: 10.1186/s13049-023-01163-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 11/30/2023] [Indexed: 12/17/2023] Open
Abstract
INTRODUCTION Survival from refractory out of hospital cardiac arrest (OHCA) without timely return of spontaneous circulation (ROSC) utilising conventional advanced cardiac life support (ACLS) therapies is dismal. CHEER3 was a safety and feasibility study of pre-hospital deployed extracorporeal membrane oxygenation (ECMO) during cardiopulmonary resuscitation (ECPR) for refractory OHCA in metropolitan Australia. METHODS This was a single jurisdiction, single-arm feasibility study. Physicians, with pre-existing ECMO expertise, responded to witnessed OHCA, age < 65 yrs, within 30 min driving-time, using an ECMO equipped rapid response vehicle. If pre-hospital ECPR was undertaken, patients were transported to hospital for investigations and therapies including emergent coronary catheterisation, and standard intensive care (ICU) therapy until either cardiac and neurological recovery or palliation occurred. Analyses were descriptive. RESULTS From February 2020 to May 2023, over 117 days, the team responded to 709 "potential cardiac arrest" emergency calls. 358 were confirmed OHCA. Time from emergency call to scene arrival was 27 min (15-37 min). 10 patients fulfilled the pre-defined inclusion criteria and all were successfully cannulated on scene. Time from emergency call to ECMO initiation was 50 min (35-62 min). Time from decision to ECMO support was 16 min (11-26 min). CPR duration was 46 min (32-62 min). All 10 patients were transferred to hospital for investigations and therapy. 4 patients (40%) survived to hospital discharge neurologically intact (CPC 1/2). CONCLUSION Pre-hospital ECPR was feasible, using an experienced ECMO team from a single-centre. Overall survival was promising in this highly selected group. Further prospective studies are now warranted.
Collapse
Affiliation(s)
- S A C Richardson
- The Alfred Hospital, Melbourne, Australia.
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
| | - D Anderson
- The Alfred Hospital, Melbourne, Australia
- Ambulance Victoria, Melbourne, Australia
- Department of Paramedicine, Monash University, Melbourne, Australia
| | - A J C Burrell
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - T Byrne
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - J Coull
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - A Diehl
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - D Gantner
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - K Hoffman
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - A Hooper
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - S Hopkins
- Ambulance Victoria, Melbourne, Australia
| | - J Ihle
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - P Joyce
- The Alfred Hospital, Melbourne, Australia
| | - M Le Guen
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - E Mahony
- Ambulance Victoria, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - S McGloughlin
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - Z Nehme
- Ambulance Victoria, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - C P Nickson
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - P Nixon
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - J Orosz
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - B Riley
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | | | - D Stub
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - M Thornton
- Ambulance Victoria, Melbourne, Australia
| | - A Udy
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - V Pellegrino
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - S Bernard
- The Alfred Hospital, Melbourne, Australia
- Ambulance Victoria, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| |
Collapse
|
2
|
Kyriakopoulos C, Taleb I, Wever-Pinzon O, Selzman C, Bonios M, Dranow E, Wever-Pinzon J, Yin M, Tseliou E, Stehlik J, Alharethi R, Kfoury A, Hanff T, Fang J, Koliopoulou A, Sideris K, Krauspe E, Nelson M, Elmer A, Singh R, Psotka M, Birks E, Slaughter M, Koenig S, Kyvernitakis A, Hoffman K, Guglin M, Kotter J, Campbell K, Silvestry S, Vidic A, Raval N, Mehra M, Cowger J, Kanwar M, Shah P, Drakos S. Multicenter Development and Validation of a Machine Learning Model to Predict Myocardial Recovery During LVAD Support: The UCAR Score. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Borazanci E, Schram AM, Garralda E, Brana I, Vieito Villar M, Spreafico A, Oliva M, Lakhani NJ, Hoffman K, Hallett RM, Maetzel D, Hua F, Hilbert J, Giblin P, Anido J, Kelly A, Vickers PJ, Wasserman R, Seoane J, Siu LL, Hyman DM, Hoff DV, Tabernero J. Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors. ESMO Open 2022; 7:100530. [PMID: 35921760 PMCID: PMC9434412 DOI: 10.1016/j.esmoop.2022.100530] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Revised: 05/26/2022] [Accepted: 06/09/2022] [Indexed: 11/17/2022] Open
Affiliation(s)
| | - A M Schram
- Memorial Sloan Kettering Cancer Center, New York, USA
| | - E Garralda
- Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain
| | - I Brana
- Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain
| | - M Vieito Villar
- Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain
| | - A Spreafico
- Princess Margaret Cancer Centre, Toronto, Canada
| | - M Oliva
- Princess Margaret Cancer Centre, Toronto, Canada
| | | | - K Hoffman
- Northern Biologics, Inc., Toronto, Canada
| | | | - D Maetzel
- Northern Biologics, Inc., Toronto, Canada
| | - F Hua
- Applied BioMath, Concord, USA
| | | | - P Giblin
- Northern Biologics, Inc., Toronto, Canada
| | - J Anido
- Northern Biologics, Inc., Toronto, Canada
| | - A Kelly
- Northern Biologics, Inc., Toronto, Canada
| | | | | | - J Seoane
- Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Universitat Autònoma de Barcelona (UAB), CIBERONC, Barcelona
| | - L L Siu
- Princess Margaret Cancer Centre, Toronto, Canada
| | - D M Hyman
- Memorial Sloan Kettering Cancer Center, New York, USA
| | | | - J Tabernero
- Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain; UVic-UCC, IOB-Quiron, Barcelona, Spain
| |
Collapse
|
4
|
Chang D, Basu S, Micheletti R, Maverakis E, Marinkovich M, Porter D, Abedi M, Weng W, Hoffman K, Volkov J, Nunez D, Milone M, Binder G, Payne A. LB952 A phase 1 trial of DSG3-CAART cells in mucosal-dominant pemphigus vulgaris (mPV) patients: Preliminary data. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.971] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Kyriakopoulos C, Taleb I, Wever-Pinzon O, Selzman C, Kfoury A, Tseliou E, Stehlik J, Alharethi R, Fang J, Catino A, Koliopoulou A, Goodwin M, Kagawa H, Dranow E, Singh R, Psotka M, Birks E, Slaughter M, Koenig S, Kyvernitakis A, Hoffman K, Guglin M, Kotter J, Vidic A, Silvestry S, Raval N, Kanwar M, Shah P, Drakos S. Multicenter-Derived Clinical Score Predicts Structural and Functional Cardiac Improvement in Chronic Heart Failure Patients Undergoing Mechanical Circulatory Support. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
6
|
Nance D, Rappazzo KM, Jensen ET, Hoffman K, Cotton CC, Krajewski AK, Turner KO, Genta RM, Lobdell DT, Dellon ES. Increased risk of eosinophilic esophagitis with poor environmental quality as measured by the Environmental Quality Index. Dis Esophagus 2021; 34:6307361. [PMID: 34155508 DOI: 10.1093/dote/doab041] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Revised: 05/21/2021] [Accepted: 05/30/2021] [Indexed: 12/11/2022]
Abstract
Geographic differences in eosinophilic esophagitis (EoE) prevalence suggest the possibility that environmental exposures contribute to EoE pathogenesis. We aimed to examine the association between environmental quality and risk of EoE, using the Environmental Quality Index (EQI), which provides quantification of environmental quality in five domains: air, land, water, built, and sociodemographic for all counties in the United States. To do this, we performed a case-control study in a large pathology database. EoE cases were defined by ≥15 eosinophils per high-power field with other pathologic diagnoses excluded; controls did not have EoE. The pathology data were geocoded and linked with the EQI by county of residence. Logistic regression was used to estimate odds ratio (OR and 95% confidence interval [CI]) of EoE with overall EQI and for each domain, after adjusting for sex, age, and proportion minority race or ethnicity at the county level (higher EQI score indicates worse environmental quality). Of 29,802 EoE cases and 593,329 controls analyzed, odds of EoE were highest in the worst quintile of EQI (OR 1.25; 95% CI: 1.04-1.50), which was largely explained by poor scores in the water domain (OR: 1.33; 1.17-1.50). Conversely, odds of EoE were reduced with higher scores in the air domain (OR: 0.87, 0.74-1.03) and land domain (OR 0.87; 0.76-0.99). Poor EQI, mostly reflected by poor water quality, was associated with increased odds of EoE, while poor air and land quality were inversely associated with EoE. Additional work to identify specific water pollutants that may have an etiologic role in EoE may be warranted.
Collapse
Affiliation(s)
- D Nance
- Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA
| | - K M Rappazzo
- United States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, Durham, NC, USA
| | - E T Jensen
- Department of Epidemiology and Prevention, Wake Forest University Public Health Sciences, Winston-Salem, NC, USA.,Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
| | - K Hoffman
- Nicholas School of the Environment, Duke University, Durham, NC, USA
| | - C C Cotton
- Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
| | - A K Krajewski
- United States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, Durham, NC, USA
| | - K O Turner
- Inform Diagnostics, Irving, TX, USA.,Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - R M Genta
- Inform Diagnostics, Irving, TX, USA.,Department of Pathology, Baylor College of Medicine, Houston, TX, USA
| | - D T Lobdell
- United States Environmental Protection Agency, Office of Research and Development, Research Triangle Park, Durham, NC, USA
| | - E S Dellon
- Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
| |
Collapse
|
7
|
Gonzalez FM, Fries EM, Cude-Woods C, Bailey T, Blatnik M, Broussard LJ, Callahan NB, Choi JH, Clayton SM, Currie SA, Dawid M, Dees EB, Filippone BW, Fox W, Geltenbort P, George E, Hayen L, Hickerson KP, Hoffbauer MA, Hoffman K, Holley AT, Ito TM, Komives A, Liu CY, Makela M, Morris CL, Musedinovic R, O'Shaughnessy C, Pattie RW, Ramsey J, Salvat DJ, Saunders A, Sharapov EI, Slutsky S, Su V, Sun X, Swank C, Tang Z, Uhrich W, Vanderwerp J, Walstrom P, Wang Z, Wei W, Young AR. Improved Neutron Lifetime Measurement with UCNτ. Phys Rev Lett 2021; 127:162501. [PMID: 34723594 DOI: 10.1103/physrevlett.127.162501] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Accepted: 07/20/2021] [Indexed: 06/13/2023]
Abstract
We report an improved measurement of the free neutron lifetime τ_{n} using the UCNτ apparatus at the Los Alamos Neutron Science Center. We count a total of approximately 38×10^{6} surviving ultracold neutrons (UCNs) after storing in UCNτ's magnetogravitational trap over two data acquisition campaigns in 2017 and 2018. We extract τ_{n} from three blinded, independent analyses by both pairing long and short storage time runs to find a set of replicate τ_{n} measurements and by performing a global likelihood fit to all data while self-consistently incorporating the β-decay lifetime. Both techniques achieve consistent results and find a value τ_{n}=877.75±0.28_{stat}+0.22/-0.16_{syst} s. With this sensitivity, neutron lifetime experiments now directly address the impact of recent refinements in our understanding of the standard model for neutron decay.
Collapse
Affiliation(s)
- F M Gonzalez
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- Center for Exploration of Energy and Matter, Indiana University, Bloomington, Indiana 47405, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - E M Fries
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - C Cude-Woods
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - T Bailey
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - M Blatnik
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - L J Broussard
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - N B Callahan
- Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - J H Choi
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - S M Clayton
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S A Currie
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M Dawid
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- Center for Exploration of Energy and Matter, Indiana University, Bloomington, Indiana 47405, USA
| | - E B Dees
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - B W Filippone
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - W Fox
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- Center for Exploration of Energy and Matter, Indiana University, Bloomington, Indiana 47405, USA
| | - P Geltenbort
- Institut Laue-Langevin, CS 20156, 38042 Grenoble Cedex 9, France
| | - E George
- Tennessee Technological University, Cookeville, Tennessee 38505, USA
| | - L Hayen
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - K P Hickerson
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - M A Hoffbauer
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - K Hoffman
- Tennessee Technological University, Cookeville, Tennessee 38505, USA
| | - A T Holley
- Tennessee Technological University, Cookeville, Tennessee 38505, USA
| | - T M Ito
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - A Komives
- DePauw University, Greencastle, Indiana 46135, USA
| | - C-Y Liu
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- Center for Exploration of Energy and Matter, Indiana University, Bloomington, Indiana 47405, USA
| | - M Makela
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - C L Morris
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R Musedinovic
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| | - C O'Shaughnessy
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R W Pattie
- East Tennessee State University, Johnson City, Tennessee 37614, USA
| | - J Ramsey
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - D J Salvat
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- Center for Exploration of Energy and Matter, Indiana University, Bloomington, Indiana 47405, USA
| | - A Saunders
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - E I Sharapov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Slutsky
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - V Su
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - X Sun
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - C Swank
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - Z Tang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - W Uhrich
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - J Vanderwerp
- Department of Physics, Indiana University, Bloomington, Indiana 47405, USA
- Center for Exploration of Energy and Matter, Indiana University, Bloomington, Indiana 47405, USA
| | - P Walstrom
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Z Wang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - W Wei
- Kellogg Radiation Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - A R Young
- Department of Physics, North Carolina State University, Raleigh, North Carolina 27695, USA
- Triangle Universities Nuclear Laboratory, Durham, North Carolina 27708, USA
| |
Collapse
|
8
|
Krosschell K, Brown L, Hoffman K, Weigel C, Munson H, Bidwell J, DiDonato C, Kuntz N, Rao V. SMA: REGISTRIES, BIOMARKERS & OUTCOME MEASURES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Scharf VF, Oblak ML, Hoffman K, Skinner OT, Neal KM, Cocca CJ, Duffy DJ, Wallace ML. Clinical features and outcome of functional thyroid tumours in 70 dogs. J Small Anim Pract 2020; 61:504-511. [PMID: 32692404 DOI: 10.1111/jsap.13183] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2020] [Revised: 04/30/2020] [Accepted: 05/20/2020] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To describe the clinical features and outcome of functional thyroid tumours in dogs. MATERIALS AND METHODS Retrospective multi-institutional study of 70 dogs diagnosed with thyroid mass and concurrent hyperthyroidism. Clinical data regarding presentation, treatment, outcome and functional thyroid status were retrieved. RESULTS Overall median survival of dogs with functional thyroid tumours was 35.1 months and 1- and 3-year survival rates were 83 and 49%, respectively. Median survival time was 72.6 months for dogs treated with surgical excision and 15.7 months for dogs that did not receive surgery. Of the 50 dogs treated by surgery and for which thyroid status was known following treatment, 64% developed hypothyroidism after surgery. Histopathologically confirmed metastasis was identified in 3% of dogs. CLINICAL SIGNIFICANCE Dogs with functional thyroid tumours may survive a long time after surgical excision, although post-operative hypothyroidism is common.
Collapse
Affiliation(s)
- V F Scharf
- College of Veterinary Medicine, North Carolina State University, 1060 William Moore Dr., Raleigh, North Carolina, USA
| | - M L Oblak
- Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada
| | - K Hoffman
- Nicholas School of the Environment, Duke University, 9 Circuit Drive, Box 90328, Durham, North Carolina, USA
| | - O T Skinner
- Veterinary Health Center, University of Missouri, 900 E Campus Dr., Columbia, Missouri, 65211, USA
| | - K M Neal
- College of Veterinary Medicine, University of Georgia, 501 D.W. Brooks Drive, Athens, Georgia, 30602, USA
| | - C J Cocca
- College of Veterinary Medicine, University of Illinois, Urbana, Illinois, USA
| | - D J Duffy
- College of Veterinary Medicine, North Carolina State University, 1060 William Moore Dr., Raleigh, North Carolina, USA
| | - M L Wallace
- College of Veterinary Medicine, University of Georgia, 501 D.W. Brooks Drive, Athens, Georgia, 30602, USA
| |
Collapse
|
10
|
Taleb I, Wever-Pinzon O, Yin M, Kfoury A, Caine W, Stehlik J, Catino A, Wever-Pinzon J, Bonios M, McKellar S, Alharethi R, Koliopoulou A, Fang J, Selzman C, Dranow E, Shah P, Singh R, Psotka M, Zhu W, Slaughter M, Birks E, Koenig S, Kanwar M, Kyvernitakis A, Hoffman K, Guglin M, Kotter J, Campbell K, Drakos S. Predicting Cardiac Structural and Functional Improvement Induced by Mechanical Unloading in Chronic Heart Failure: A Derivation-Validation Multicenter Study. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
11
|
Borazanci E, Schram A, Brana I, Villar MV, Garralda E, Spreafico A, Oliva M, Lakhani N, Wasserman R, Hoffman K, Hallett R, Anido J, Giblin P, Pandya N, Kelly A, Seoane J, Von Hoff D, Siu L, Hyman D, Tabernero J. Phase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz253.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
12
|
Pattie R, Callahan N, Cude-Woods C, Adamek E, Adams M, Barlow D, Blatnik M, D. B, Broussard L, Clayton S, Currie S, Dees E, Ding X, Fellers D, Fox W, Fries E, Gonzalez F, Geltenbort P, Hickerson K, Hoffbauer M, Hoffman K, Holley A, Howard D, Ito T, Komives A, Liu C, M. M, Medina J, Morley D, Morris C, O'Connor T, Penttilä S, Ramsey J, Roberts A, Salvat D, Saunders A, Seestrom S, Sharapov E, Sjue S, Snow W, Sprow A, Vanderwerp J, Vogelaar B, P.L. W, Wang Z, Weaver H, Wexler J, Womack T, Young A, Zeck B. Status of the UCN τ experiment. EPJ Web Conf 2019. [DOI: 10.1051/epjconf/201921903004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The neutron is the simplest nuclear system that can be used to probe the structure of the weak interaction and search for physics beyond the standard model. Measurements of neutron lifetime and β-decay correlation coefficients with precisions of 0.02% and 0.1%, respectively, would allow for stringent constraints on new physics. The UCNτ experiment uses an asymmetric magneto-gravitational UCN trap with in situ counting of surviving neutrons to measure the neutron lifetime, τn = 877.7s (0.7s)stat (+0.4/−0.2s)sys. We discuss the recent result from UCNτ, the status of ongoing data collection and analysis, and the path toward a 0.25 s measurement of the neutron lifetime with UCNτ.
Collapse
|
13
|
Rizwan M, Naoman S, Wickwire E, Diaz-Abad M, Hoffman K, Scharf SM. 0607 Feasibility Of Unattended Sleep Apnea Screening In Inpatients. Sleep 2018. [DOI: 10.1093/sleep/zsy061.606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Rizwan
- University of Maryland, Baltimore, MD
| | - S Naoman
- University of Maryland, Baltimore, MD
| | | | | | - K Hoffman
- University of Maryland, Baltimore, MD
| | | |
Collapse
|
14
|
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 2018; 359:97-103. [PMID: 29097493 PMCID: PMC5827966 DOI: 10.1126/science.aan4236] [Citation(s) in RCA: 2689] [Impact Index Per Article: 448.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Accepted: 10/17/2017] [Indexed: 12/11/2022]
Abstract
Preclinical mouse models suggest that the gut microbiome modulates tumor response to checkpoint blockade immunotherapy; however, this has not been well-characterized in human cancer patients. Here we examined the oral and gut microbiome of melanoma patients undergoing anti-programmed cell death 1 protein (PD-1) immunotherapy (n = 112). Significant differences were observed in the diversity and composition of the patient gut microbiome of responders versus nonresponders. Analysis of patient fecal microbiome samples (n = 43, 30 responders, 13 nonresponders) showed significantly higher alpha diversity (P < 0.01) and relative abundance of bacteria of the Ruminococcaceae family (P < 0.01) in responding patients. Metagenomic studies revealed functional differences in gut bacteria in responders, including enrichment of anabolic pathways. Immune profiling suggested enhanced systemic and antitumor immunity in responding patients with a favorable gut microbiome as well as in germ-free mice receiving fecal transplants from responding patients. Together, these data have important implications for the treatment of melanoma patients with immune checkpoint inhibitors.
Collapse
Affiliation(s)
- V Gopalakrishnan
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA
| | - C N Spencer
- Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - L Nezi
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - A Reuben
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - M C Andrews
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - T V Karpinets
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - P A Prieto
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - D Vicente
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - K Hoffman
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - S C Wei
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - A P Cogdill
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - L Zhao
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - C W Hudgens
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - D S Hutchinson
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
| | - T Manzo
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - M Petaccia de Macedo
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - T Cotechini
- Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA
| | - T Kumar
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - W S Chen
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - S M Reddy
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - R Szczepaniak Sloane
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J Galloway-Pena
- Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - H Jiang
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - P L Chen
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - E J Shpall
- Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - K Rezvani
- Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - A M Alousi
- Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - R F Chemaly
- Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - S Shelburne
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - L M Vence
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - P C Okhuysen
- Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - V B Jensen
- Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - A G Swennes
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
| | - F McAllister
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - E Marcelo Riquelme Sanchez
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Y Zhang
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - E Le Chatelier
- Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France
| | - L Zitvogel
- Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France
| | - N Pons
- Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France
| | - J L Austin-Breneman
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - L E Haydu
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - E M Burton
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J M Gardner
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - E Sirmans
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J Hu
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - A J Lazar
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - T Tsujikawa
- Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA
| | - A Diab
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - H Tawbi
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - I C Glitza
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - W J Hwu
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - S P Patel
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - S E Woodman
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - R N Amaria
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - M A Davies
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J E Gershenwald
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - P Hwu
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J E Lee
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J Zhang
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - L M Coussens
- Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA
| | - Z A Cooper
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - P A Futreal
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - C R Daniel
- Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA
| | - N J Ajami
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
| | - J F Petrosino
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
| | - M T Tetzlaff
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - P Sharma
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J P Allison
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - R R Jenq
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - J A Wargo
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| |
Collapse
|
15
|
Mcinnis D, Hendrichs J, Shelly T, Barr N, Hoffman K, Rodriguez R, Lance D, Bloem K, Suckling D, Enkerlin W, Gomes P, Tan K. Can Polyphagous Invasive Tephritid Pest Populations Escape Detection for Years Under Favorable Climatic and Host Conditions? ACTA ACUST UNITED AC 2017. [DOI: 10.1093/ae/tmx038] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
16
|
Locatelli F, Mauz-Koerholz C, Neville K, Llort A, Beishuizen A, Daw S, Pillon M, Aladjidi N, Klingebiel T, Landman-Parker J, Medina-Sanson A, August K, Huebner D, Sachs J, Hoffman K, Kinley J, Song S, Song G, Zhang S, Gore L. A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE-CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL). Hematol Oncol 2017. [DOI: 10.1002/hon.2438_111] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- F. Locatelli
- Department of Pediatric Haematology-Oncology; University of Pavia; Rome Italy
| | - C. Mauz-Koerholz
- Pediatric Hematology and Oncology; University Hospital Giessen, Justus-Liebig University of Giessen; Giessen Germany
| | - K. Neville
- Division of Hematology and Oncology; Arkansas Children's Hospital; Little Rock USA
| | - A. Llort
- Laboratory of Translational Research in Pediatric Cancer; Vall d'Hebron Research Institute; Barcelona Spain
| | - A. Beishuizen
- Department of Pediatric Oncology/Hematology; Erasmus MC-Sophia Children's Hospital; Rotterdam Netherlands
| | - S. Daw
- Department Paediatric and Adolescent Oncology; University College London Hospital NHS Foundation Trust; London UK
| | - M. Pillon
- Clinic of Paediatric Haemato-Oncology, Department of Women's and Children's Health; University of Padova; Padova Italy
| | - N. Aladjidi
- Pediatric Hematology Unit, CIC 1401 Inserm CICP, Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE) Hôpital des Enfants; Hôpital Pellegrin; CHU Bordeaux France
| | - T. Klingebiel
- Clinic for Pediatric and Adolescent Medicine; University Hospital; Frankfurt Germany
| | - J. Landman-Parker
- Service d'Hématologie et d'Oncologie Pédiatrique, Hopital A, Trousseau; University of Paris; Paris France
| | - A. Medina-Sanson
- Departamento de Hemato-Oncología; Hospital Infantil de México Federico Gómez, Secretaria de Salud (SS); Ciudad de México Mexico
| | - K. August
- Pediatrics; Children's Mercy Hospital and Clinics; Kansas City USA
| | - D. Huebner
- Oncology; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - J. Sachs
- Oncology Clinical Research; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - K. Hoffman
- Clinical Operations; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - J. Kinley
- Oncology Clinical Research; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - S. Song
- Translational Medicine, Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - G. Song
- Oncology Statistics; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - S. Zhang
- Quantitative Clinical Pharmacology; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Inc.; Cambridge USA
| | - L. Gore
- Department of Pediatrics; University of Colorado School of Medicine and Center for Cancer and Blood Disorders, Childrens Hospital Colorado; Aurora USA
| |
Collapse
|
17
|
Kivitz A, Hazan L, Hoffman K, Wallin B. FRI0209 MORAb-022, An Anti-Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Monoclonal Antibody (MAB): Results of The First Study in Patients with Mild-To-Moderate Rheumatoid Arthritis (RA): Table 1. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3186] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Braga J, Loubes JM, Descouens D, Dumoncel J, Thackeray JF, Kahn JL, de Beer F, Riberon A, Hoffman K, Balaresque P, Gilissen E. Disproportionate Cochlear Length in Genus Homo Shows a High Phylogenetic Signal during Apes' Hearing Evolution. PLoS One 2015; 10:e0127780. [PMID: 26083484 PMCID: PMC4471221 DOI: 10.1371/journal.pone.0127780] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2014] [Accepted: 04/18/2015] [Indexed: 11/30/2022] Open
Abstract
Changes in lifestyles and body weight affected mammal life-history evolution but little is known about how they shaped species’ sensory systems. Since auditory sensitivity impacts communication tasks and environmental acoustic awareness, it may have represented a deciding factor during mammal evolution, including apes. Here, we statistically measure the influence of phylogeny and allometry on the variation of five cochlear morphological features associated with hearing capacities across 22 living and 5 fossil catarrhine species. We find high phylogenetic signals for absolute and relative cochlear length only. Comparisons between fossil cochleae and reconstructed ape ancestral morphotypes show that Australopithecus absolute and relative cochlear lengths are explicable by phylogeny and concordant with the hypothetized ((Pan,Homo),Gorilla) and (Pan,Homo) most recent common ancestors. Conversely, deviations of the Paranthropus oval window area from these most recent common ancestors are not explicable by phylogeny and body weight alone, but suggest instead rapid evolutionary changes (directional selection) of its hearing organ. Premodern (Homo erectus) and modern human cochleae set apart from living non-human catarrhines and australopiths. They show cochlear relative lengths and oval window areas larger than expected for their body mass, two features corresponding to increased low-frequency sensitivity more recent than 2 million years ago. The uniqueness of the “hypertrophied” cochlea in the genus Homo (as opposed to the australopiths) and the significantly high phylogenetic signal of this organ among apes indicate its usefulness to identify homologies and monophyletic groups in the hominid fossil record.
Collapse
Affiliation(s)
- J. Braga
- Hominid Evolutionary Biology, AMIS-UMR 5288 CNRS, University of Toulouse (Paul Sabatier), Toulouse, France
- Evolutionary Studies Institute, University of the Witwatersrand, Johannesburg, South Africa
- * E-mail:
| | - J-M. Loubes
- Statistics and Probabilities Team, Institute of Mathematics of Toulouse, UMR 5219 CNRS-Université de Toulouse (Paul Sabatier), Toulouse, France
| | - D. Descouens
- Hominid Evolutionary Biology, AMIS-UMR 5288 CNRS, University of Toulouse (Paul Sabatier), Toulouse, France
| | - J. Dumoncel
- Hominid Evolutionary Biology, AMIS-UMR 5288 CNRS, University of Toulouse (Paul Sabatier), Toulouse, France
| | - J. F. Thackeray
- Evolutionary Studies Institute, University of the Witwatersrand, Johannesburg, South Africa
| | - J-L. Kahn
- Institut d'Anatomie Normale et Pathologique, Faculté de Médecine de Strasbourg, Strasbourg, France
| | - F. de Beer
- South African Nuclear Energy Corporation, Pelindaba, North West Province, South Africa
| | - A. Riberon
- Laboratoire Evolution et Diversité Biologique, UMR 5174 CNRS, University of Toulouse (Paul Sabatier), Toulouse, France
| | - K. Hoffman
- South African Nuclear Energy Corporation, Pelindaba, North West Province, South Africa
| | - P. Balaresque
- Hominid Evolutionary Biology, AMIS-UMR 5288 CNRS, University of Toulouse (Paul Sabatier), Toulouse, France
| | - E. Gilissen
- Royal Museum for Central Africa, Tervuren, Belgium and Laboratory of Histology and Neuropathology, Université libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
19
|
Hoffman K, Silvester L, Nott P, Goodfellow T, Richardson D, Wolstenholme S, Turnbull J, Jenks T, Brohi K. Evaluation of the value of rehabilitation prescriptions within four major trauma hospitals. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.3408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Strom E, Amos R, Shaitelman S, Kerr M, Hoffman K, Smith B, Amin M, Wang X, Poenisch F, Woodward W. Prospective Phase 2 Proton APBI: Multibeam Supine Treatment Is Reproducible and Free From Acute Toxicity. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.752] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
21
|
Ponce-Terashima J, Mozena A, Hoffman K, McCarty D, Fiestas F, Ferrand MP. SY03-2-2 * NIDA-ISAM FELLOWSHIP LIFETIME PREVALENCE OF ALCOHOL USE DISORDERS IN PERU: FINDINGS FROM THE WORLD MENTAL HEALTH STUDY. Alcohol Alcohol 2014. [DOI: 10.1093/alcalc/agu052.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Du W, Cho S, Zhang X, Hoffman K, Kudchadker R. SU-E-T-353: Decoding the Beam Complexity in Intensity-Modulated Radiation Therapy Plans. Med Phys 2014. [DOI: 10.1118/1.4888686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
23
|
Woodward WA, Arriaga L, Gao H, Cohen EN, Li L, Reuben JM, Munsell MF, Valero V, Le-Petross H, Melhem-Betrandt A, Moulder S, Middleton LP, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. Abstract P5-14-08: Prospective phase II study of concurrent capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p5-14-08] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Capecitabine is an established radiosensitizer in rectal and other cancers. We conducted a prospective single arm phase II study to examine the response rate of gross chemo-refractory breast cancer treated with concurrent capecitabine and radiotherapy.
Methods: Patients who had inoperable or marginally operable gross disease in the breast and/or lymph node(s) after chemotherapy or gross disease on the chest wall or in the regional lymphatics after mastectomy were eligible. Patients 1-9 received capecitabine 825 mg/m2 BID daily beginning on the first day of radiotherapy. Excess grade 3 toxicity (%) was observed; the protocol was amended and subsequent patients received drug only on radiation treatment days. Radiation dose was at the discretion of the treating physician (50Gy-72 Gy, with no more than 2.5 Gy/fraction). Response was assessed by a single physician using paired radiation planning CTs (pretreatment and on-treatment after 45 Gy). Clinical correlation to all other available imaging was also made. Kaplan-Meier curves were used to estimate overall survival (OS) and local recurrence-free survival (LRFS). Circulating tumor cells (CTCs) in blood were examined in consenting patients.
Results: The trial was stopped early after an unplanned interim analysis prompted by slow accrual suggested futility independent of response. From 2009-2012, 32 patients were accrued; 26 completed protocol specific treatment (17 post-mastectomy radiation with gross nodes, 4 pre-op, 5 aggressive palliation) and are included in this analysis. Median follow up was 7.3 months (interquartile range 6.7 – 17.4). Nineteen patients (73%) had a partial or complete response. Fourteen patients (53.9%) experienced at least one grade 3 non-dermatitis toxicity including 7/9 treated with continuous dosing. Four inoperable patients were treated with pre-op radiation therapy and 3 converted to operable. None achieved a pCR or near pCR. One-year actuarial OS was 52%. There was no difference in OS comparing among PMRT vs. preoperative or palliative RT (P = 0.90). One-year actuarial local recurrence free survival among PMRT patients was 38%. Ten patients had triple negative (TN) receptor status. There was no difference in radiation response by receptor status (P = 0.56); however, treatment was deemed subjectively futile (i.e., converted to operable but death secondary to new widespread M1 disease immediately post-op) in 9 of the 10 patients with TN disease versus 6 of the 16 patients with non-TN disease (P = 0.014). Median OS and 1-yr actuarial OS, among non-TN vs. TN patients were not reached vs. 6.1 months and 77% vs. 10% (P < 0.001), respectively. Eight/fifteen patients tested were positive for CTCs. CTCs did not correlate to receptor status, futility of RT or OS.
Conclusions: Capecitabine can be safely administered as a daily concurrent chemoradiation regimen with weekend holidays. However, in this small, prospective and selected cohort, concurrent chemoradiation with capecitabine was futile among patients with TN breast cancer. Alternative strategies are urgently needed in TN patients.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P5-14-08.
Collapse
Affiliation(s)
- WA Woodward
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - L Arriaga
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - H Gao
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - EN Cohen
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - L Li
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - JM Reuben
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - MF Munsell
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - V Valero
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - H Le-Petross
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | | | - S Moulder
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - LP Middleton
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - EA Strom
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - W Tereffe
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - K Hoffman
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - BD Smith
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - TA Buchholz
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - GH Perkins
- The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
24
|
Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits? Br J Radiol 2013; 86:20130176. [PMID: 23728947 PMCID: PMC3755395 DOI: 10.1259/bjr.20130176] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2013] [Revised: 05/22/2013] [Accepted: 05/29/2013] [Indexed: 11/07/2022] Open
Abstract
OBJECTIVE Passive scattering proton beam (PSPB) radiotherapy for accelerated partial-breast irradiation (APBI) provides superior dosimetry for APBI three-dimensional conformal photon radiotherapy (3DCRT). Here we examine the potential incremental benefit of intensity-modulated proton radiotherapy (IMPT) for APBI and compare its dosimetry with PSPB and 3DCRT. METHODS Two theoretical IMPT plans, TANGENT_PAIR and TANGENT_ENFACE, were created for 11 patients previously treated with 3DCRT APBI and were compared with PSPB and 3DCRT plans for the same CT data sets. The impact of range, motion and set-up uncertainties as well as scanned spot mismatching between fields of IMPT plans was evaluated. RESULTS IMPT plans for APBI were significantly better regarding breast skin sparing (p<0.005) and other normal tissue sparing than 3DCRT plans (p<0.01) with comparable target coverage (p=ns). IMPT plans were statistically better than PSPB plans regarding breast skin (p<0.002) and non-target breast (p<0.007) in higher dose regions but worse or comparable in lower dose regions. IMPT plans using TANGENT_ENFACE were superior to that using TANGENT_PAIR in terms of target coverage (p<0.003) and normal tissue sparing (p<0.05) in low-dose regions. IMPT uncertainties were demonstrated for multiple causes. Qualitative comparison of dose-volume histogram confidence intervals for IMPT suggests that numeric gains may be offset by IMPT uncertainties. CONCLUSION Using current clinical dosimetry, PSPB provides excellent dosimetry compared with 3DCRT with fewer uncertainties compared with IMPT. ADVANCES IN KNOWLEDGE As currently delivered in the clinic, PSPB planning for APBI provides as good or better dosimetry than IMPT with less uncertainty.
Collapse
Affiliation(s)
- X Wang
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Hoit G, Hinkewich C, Tiao J, Porgo V, Moore L, Moore L, Tiao J, Wang C, Moffatt B, Wheeler S, Gillman L, Bartens K, Lysecki P, Pallister I, Patel S, Bradford P, Bradford P, Kidane B, Holmes A, Trajano A, March J, Lyons R, Kao R, Rezende-Neto J, Leblanc Y, Rezende-Neto J, Vogt K, Alzaid S, Jansz G, Andrusiek D, Andrusiek D, Bailey K, Livingston M, Calthorpe S, Hsu J, Lubbert P, Boitano M, Leeper W, Williamson O, Reid S, Alonazi N, Lee C, Rezende-Neto J, Aleassa E, Jennings P, Jennings P, Mador B, Hoffman K, Riley J, Vu E, Alburakan A, Alburakan A, Alburakan A, Mckee J, Bobrovitz N, Gabbe B, Gabbe B, Hodgkinson J, Hodgkinson J, Ali J, Ali J, Grant M, Roberts D, Holodinsky J, Cooper C, Santana M, Kruger K, Hodgkinson J, Waggott M, Da Luz L, Banfield J, Santana M, Dorigatti A, Birn K, Bobrovitz N, Zakirova R, Davies D, Das D, Gamme G, Pervaiz F, Almarhabi Y, Brainard A, Brown R, Bell N, Bell N, Jowett H, Jowett H, Bressan S, Hogan A, Watson I, Woodford S, Hogan A, Boulay R, Watson I, Howlett M, Atkinson P, Chesters A, Hamadani F, Atkinson P, Azzam M, Fraser J, Doucet J, Atkinson P, Muakkassa F, Sathivel N, Chadi S, Joseph B, Takeuchi L, Bradley N, Al Bader B, Kidane B, Harrington A, Nixon K, Veigas P, Joseph B, O’Keeffe T, Bracco D, Rezende-Neto J, Azzam M, Lin Y, Bailey K, Bracco D, Nash N, Alhabboubi M, Slobogean G, Spicer J, Heidary B, Joos E, Berg R, Berg R, Sankarankutty A, Zakrison T, Babul S, Lockhart S, Faux S, Jackson A, Lee T, Bailey K, Pemberton J, Green R, Tallon J, Moore L, Turgeon A, Boutin A, Moore L, Reinartz D, Lapointe G, Turgeon A, Stelfox H, Turgeon A, Nathens A, Neveu X, Stelfox H, Turgeon A, Nathens A, Neveu X, Moore L, Turgeon A, Bratu I, Gladwin C, Voaklander D, Lewis M, Vogt K, Eckert K, Williamson J, Stewart TC, Parry N, Gray D, L’Heureux R, Ziesmann M, Kortbeek J, Brindley P, Hicks C, Fata P, Engels P, Ball C, Paton-Gay D, Widder S, Vogt K, Hernandez-Alejandro R, Gray D, Vanderbeek L, Forrokhyar F, Anatharajah R, Howatt N, Lamb S, Sne N, Kahnamoui K, Lyons R, Walters A, Brooks C, Pinder L, Rahman S, Walters A, Kidane B, Parry N, Donnelly E, Lewell M, Mellow R, Hedges C, Morassutti P, Bulatovic R, Morassutti P, Galbraith E, McKenzie S, Bradford D, Lewell M, Peddle M, Dukelow A, Eby D, McLeod S, Bradford P, Stewart TC, Parry N, Williamson O, Fraga G, Pereira B, Sareen J, Doupe M, Gawaziuk J, Chateau D, Logsetty S, Pallister I, Lewis J, O’Doherty D, Hopkins S, Griffiths S, Palmer S, Gabbe B, Xu X, Martin C, Xenocostas A, Parry N, Mele T, Rui T, Abreu E, Andrade M, Cruz F, Pires R, Carreiro P, Andrade T, Lampron J, Balaa F, Fortuna R, Issa H, Dias P, Marques M, Fernandes T, Sousa T, Inaba K, Smith J, Okoye O, Joos E, Shulman I, Nelson J, Parry N, Rhee P, Demetriades D, Ostrofsky R, Butler-Laporte G, Chughtai T, Khwaja K, Fata P, Mulder D, Razek T, Deckelbaum D, Bailey K, Pemberton J, Evans D, Anton H, Wei J, Randall E, Sobolev B, Scott BB, van Heest R, Frankfurter C, Pemberton J, McKerracher S, Stewart TC, Merritt N, Barber L, Kimmel L, Hodgson C, Webb M, Holland A, Gruen R, Harrison K, Hwang M, Hsee L, Civil I, Muizelaar A, Baillie F, Leeper T, Stewart TC, Gray D, Parry N, Sutherland A, Hart M, Gabbe B, Tuma F, Coates A, Farrokhyar F, Faidi S, Gastaldo F, Paskar D, Reid S, Faidi S, Petrisor B, Bhandari M, Loh WL, Ho C, Chong C, Rodrigues G, Gissoni M, Martins M, Andrade M, Cunha-Melo J, Rizoli S, Abu-Zidan F, Cameron P, Bernard S, Walker T, Jolley D, Fitzgerald M, Masci K, Gabbe B, Simpson P, Smith K, Cox S, Cameron P, Evans D, West A, Barratt L, Rozmovits L, Livingstone B, Vu M, Griesdale D, Schlamp R, Wand R, Alhabboubi M, Alrowaili A, Alghamdi H, Fata P, Essbaiheen F, Alhabboubi M, Fata P, Essbaiheen F, Chankowsky J, Razek T, Stephens M, Vis C, Belton K, Kortbeek J, Bratu I, Dufresne B, Guilfoyle J, Ibbotson G, Martin K, Matheson D, Parks P, Thomas L, Kirkpatrick A, Santana M, Kline T, Kortbeek J, Stelfox H, Lyons R, Macey S, Fitzgerald M, Judson R, Cameron P, Sutherland A, Hart M, Morgan M, McLellan S, Wilson K, Cameron P, Sorvari A, Chaudhry Z, Khawaja K, Ali A, Akhtar J, Zubair M, Nickow J, Sorvari A, Holodinsky J, Jaeschke R, Ball C, Blaser AR, Starkopf J, Zygun D, Kirkpatrick A, Roberts D, Ball C, Blaser AR, Starkopf J, Zygun D, Jaeschke R, Kirkpatrick A, Santana M, Stelfox H, Stelfox H, Rizoli S, Tanenbaum B, Stelfox H, Redondano BR, Jimenez LS, Zago T, de Carvalho RB, Calderan TA, Fraga G, Campbell S, Widder S, Paton-Gay D, Engels P, Ferri M, Santana M, Kline T, Kortbeek J, Stelfox H, Nathens A, Lashoher A, McFarlan A, Ahmed N, Booy J, McDowell D, Nasr A, Wales P, Roberts D, Mercado M, Vis C, Kortbeek J, Kirkpatrick A, Lall R, Stelfox H, Ball C, Niven D, Dixon E, Stelfox H, Kirkpatrick A, Kaplan G, Hameed M, Ball C, Qadura M, Sne N, Reid S, Coates A, Faidi S, Veenstra J, Hennecke P, Gardner R, Appleton L, Sobolev B, Simons R, van Heest R, Hameed M, Sobolev B, Simons R, van Heest R, Hameed M, Palmer C, Bevan C, Crameri J, Palmer C, Hogan D, Grealy L, Bevan C, Palmer C, Jowett H, Boulay R, Chisholm A, Beairsto E, Goulette E, Martin M, Benjamin S, Boulay R, Watson I, Boulay R, Watson I, Watson I, Savoie J, Benjamin S, Martin M, Hogan A, Woodford S, Benjamin S, Chisholm A, Ondiveeran H, Martin M, Atkinson P, Doody K, Fraser J, Leblanc-Duchin D, Strack B, Naveed A, vanRensburg L, Madan R, Atkinson P, Boulva K, Deckelbaum D, Khwaja K, Fata P, Razek T, Fraser J, Verheul G, Parks A, Milne J, Nemeth J, Fata P, Correa J, Deckelbaum D, Bernardin B, Al Bader B, Khwaja K, Razek T, Atkinson P, Benjamin S, Sproul E, Mehta A, Galarneau M, Mahadevan P, Bansal V, Dye J, Hollingsworth-Fridlund P, Stout P, Potenza B, Coimbra R, Madan R, Marley R, Salvator A, Pisciotta D, Bridge J, Lin S, Ovens H, Nathens A, Abdo H, Dencev-Bihari R, Parry N, Lawendy A, Ibrahim-Zada I, Pandit V, Tang A, O’Keeffe T, Wynne J, Gries L, Friese R, Rhee P, Hameed M, Simons R, Taulu T, Wong H, Saleem A, Azzam M, Boulva K, Razek T, Khwaja K, Mulder D, Deckelbaum D, Fata P, Plourde M, Chadi S, Forbes T, Parry N, Martin G, Gaunt K, Bandiera G, Bawazeer M, MacKinnon D, Ahmed N, Spence J, Sankarankutty A, Nascimento B, Rizoli S, Ibrahim-Zada I, Aziz H, Tang A, Friese R, Wynne J, O’keeffe T, Vercruysse G, Kulvatunyou N, Rhee P, Sakles J, Mosier J, Wynne J, Kulvatunyou N, Tang A, Joseph B, Rhee P, Khwaja K, Fata P, Deckelbaum D, Razek T, Dias P, Issa H, Fortuna R, Sousa T, Abreu E, Bracco D, Khwaja K, Fata P, Deckelbaum D, Razek T, Bracco D, Khwaja K, Fata P, Deckelbaum D, Razek T, Norman D, Li J, Pemberton J, Al-Oweis J, Khwaja K, Fata P, Deckelbaum D, Razek T, Albuz O, Karamanos E, Vogt K, Okoye O, Talving P, Inaba K, Demetriades D, Elhusseini M, Sudarshan M, Deckelbaum D, Fata P, Razek T, Khwaja K, MacPherson C, Sun T, Pelletier M, Hameed M, Khalil MA, Azzam M, Valenti D, Fata P, Deckelbaum D, Razek T, Brown R, Simons R, Evans D, Hameed M, Inaba K, Vogt K, Okoye O, Gelbard R, Moe D, Grabo D, Demetriades D, Inaba K, Karamanos E, Okoye O, Talving P, Demetriades D, Inaba K, Karamanos E, Pasley J, Teixeira P, Talving P, Demetriades D, Fung S, Alababtain I, Brnjac E, Luz L, Nascimento B, Rizoli S, Parikh P, Proctor K, Murtha M, Schulman C, Namias N, Goldman R, Pike I, Korn P, Flett C, Jackson T, Keith J, Joseph T, Giddins E, Ouellet J, Cook M, Schreiber M, Kortbeek J. Trauma Association of Canada (TAC) Annual Scientific Meeting. The Westin Whistler Resort & Spa, Whistler, BC, Thursday, Apr. 11 to Saturday, Apr. 13, 2013Testing the reliability of tools for pediatric trauma teamwork evaluation in a North American high-resource simulation settingThe association of etomidate with mortality in trauma patientsDefinition of isolated hip fractures as an exclusion criterion in trauma centre performance evaluations: a systematic reviewEstimation of acute care hospitalization costs for trauma hospital performance evaluation: a systematic reviewHospital length of stay following admission for traumatic injury in Canada: a multicentre cohort studyPredictors of hospital length of stay following traumatic injury: a multicentre cohort studyInfluence of the heterogeneity in definitions of an isolated hip fracture used as an exclusion criterion in trauma centre performance evaluations: a multicentre cohort studyPediatric trauma, advocacy skills and medical studentsCompliance with the prescribed packed red blood cell, fresh frozen plasma and platelet ratio for the trauma transfusion pathway at a level 1 trauma centreEarly fixed-wing aircraft activation for major trauma in remote areasDevelopment of a national, multi-disciplinary trauma crisis resource management curriculum: results from the pilot courseThe management of blunt hepatic trauma in the age of angioembolization: a single centre experienceEarly predictors of in-hospital mortality in adult trauma patientsThe impact of open tibial fracture on health service utilization in the year preceding and following injuryA systematic review and meta-analysis of the efficacy of red blood cell transfusion in the trauma populationSources of support for paramedics managing work-related stress in a Canadian EMS service responding to multisystem trauma patientsAnalysis of prehospital treatment of pain in the multisystem trauma patient at a community level 2 trauma centreIncreased mortality associated with placement of central lines during trauma resuscitationChronic pain after serious injury — identifying high risk patientsEpidemiology of in-hospital trauma deaths in a Brazilian university teaching hospitalIncreased suicidality following major trauma: a population-based studyDevelopment of a population-wide record linkage system to support trauma researchInduction of hmgb1 by increased gut permeability mediates acute lung injury in a hemorrhagic shock and resuscitation mouse modelPatients who sustain gunshot pelvic fractures are at increased risk for deep abscess formation: aggravated by rectal injuryAre we transfusing more with conservative management of isolated blunt splenic injury? A retrospective studyMotorcycle clothesline injury prevention: Experimental test of a protective deviceA prospective analysis of compliance with a massive transfusion protocol - activation alone is not enoughAn evaluation of diagnostic modalities in penetrating injuries to the cardiac box: Is there a role for routine echocardiography in the setting of negative pericardial FAST?Achievement of pediatric national quality indicators — an institutional report cardProcess mapping trauma care in 2 regional health authorities in British Columbia: a tool to assist trauma sys tem design and evaluationPatient safety checklist for emergency intubation: a systematic reviewA standardized flow sheet improves pediatric trauma documentationMassive transfusion in pediatric trauma: a 5-year retrospective reviewIs more better: Does a more intensive physiotherapy program result in accelerated recovery for trauma patients?Trauma care: not just for surgeons. Initial impact of implementing a dedicated multidisciplinary trauma team on severely injured patientsThe role of postmortem autopsy in modern trauma care: Do we still need them?Prototype cervical spine traction device for reduction stabilization and transport of nondistraction type cervical spine injuriesGoing beyond organ preservation: a 12-year review of the beneficial effects of a nonoperative management algorithm for splenic traumaAssessing the construct validity of a global disability measure in adult trauma registry patientsThe mactrauma TTL assessment tool: developing a novel tool for assessing performance of trauma traineesA quality improvement approach to developing a standardized reporting format of ct findings in blunt splenic injuriesOutcomes in geriatric trauma: what really mattersFresh whole blood is not better than component therapy (FFP:RBC) in hemorrhagic shock: a thromboelastometric study in a small animal modelFactors affecting mortality of chest trauma patients: a prospective studyLong-term pain prevalence and health related quality of life outcomes for patients enrolled in a ketamine versus morphine for prehospital traumatic pain randomized controlled trialDescribing pain following trauma: predictors of persistent pain and pain prevalenceManagement strategies for hemorrhage due to pelvic trauma: a survey of Canadian general surgeonsMajor trauma follow-up clinic: Patient perception of recovery following severe traumaLost opportunities to enhance trauma practice: culture of interprofessional education and sharing among emergency staffPrehospital airway management in major trauma and traumatic brain injury by critical care paramedicsImproving patient selection for angiography and identifying risk of rebleeding after angioembolization in the nonoperative management of high grade splenic injuriesFactors predicting the need for angioembolization in solid organ injuryProthrombin complex concentrates use in traumatic brain injury patients on oral anticoagulants is effective despite underutilizationThe right treatment at the right time in the right place: early results and associations from the introduction of an all-inclusive provincial trauma care systemA multicentre study of patient experiences with acute and postacute injury carePopulation burden of major trauma: Has introduction of an organized trauma system made a difference?Long-term functional and return to work outcomes following blunt major trauma in Victoria, AustraliaSurgical dilemma in major burns victim: heterotopic ossification of the tempromandibular jointWhich radiological modality to choose in a unique penetrating neck injury: a differing opinionThe Advanced Trauma Life Support (ATLS) program in CanadaThe Rural Trauma Team Development Course (RTTDC) in Pakistan: Is there a role?Novel deployment of BC mobile medical unit for coverage of BMX world cup sporting eventIncidence and prevalence of intra-abdominal hypertension and abdominal compartment syndrome in critically ill adults: a systematic review and meta-analysisRisk factors for intra-abdominal hypertension and abdominal compartment syndrome in critically ill or injured adults: a systematic review and meta-analysisA comparison of quality improvement practices at adult and pediatric trauma centresInternational trauma centre survey to evaluate content validity, usability and feasibility of quality indicatorsLong-term functional recovery following decompressive craniectomy for severe traumatic brain injuryMorbidity and mortality associated with free falls from a height among teenage patients: a 5-year review from a level 1 trauma centreA comparison of adverse events between trauma patients and general surgery patients in a level 1 trauma centreProcoagulation, anticoagulation and fibrinolysis in severely bleeding trauma patients: a laboratorial characterization of the early trauma coagulopathyThe use of mobile technology to facilitate surveillance and improve injury outcome in sport and physical activityIntegrated knowledge translation for injury quality improvement: a partnership between researchers and knowledge usersThe impact of a prevention project in trauma with young and their learningIntraosseus vascular access in adult trauma patients: a systematic reviewThematic analysis of patient reported experiences with acute and post-acute injury careAn evaluation of a world health organization trauma care checklist quality improvement pilot programProspective validation of the modified pediatric trauma triage toolThe 16-year evolution of a Canadian level 1 trauma centre: growing up, growing out, and the impact of a booming economyA 20-year review of trauma related literature: What have we done and where are we going?Management of traumatic flail chest: a systematic review of the literatureOperative versus nonoperative management of flail chestEmergency department performance of a clinically indicated and technically successful emergency department thoracotomy and pericardiotomy with minimal equipment in a New Zealand institution without specialized surgical backupBritish Columbia’s mobile medical unit — an emergency health care support resourceRoutine versus ad hoc screening for acute stress: Who would benefit and what are the opportunities for trauma care?A geographical analysis of the Early Development Instrument (EDI) and childhood injuryDevelopment of a pediatric spinal cord injury nursing course“Kids die in driveways” — an injury prevention campaignEpidemiology of traumatic spine injuries in childrenA collaborative approach to reducing injuries in New Brunswick: acute care and injury preventionImpact of changes to a provincial field trauma triage tool in New BrunswickEnsuring quality of field trauma triage in New BrunswickBenefits of a provincial trauma transfer referral system: beyond the numbersThe field trauma triage landscape in New BrunswickImpact of the Rural Trauma Team Development Course (RTTDC) on trauma transfer intervals in a provincial, inclusive trauma systemTrauma and stress: a critical dynamics study of burnout in trauma centre healthcare professionalsUltrasound-guided pediatric forearm fracture reduction with sedation in the emergency departmentBlock first, opiates later? The use of the fascia iliaca block for patients with hip fractures in the emergency department: a systematic reviewRural trauma systems — demographic and survival analysis of remote traumas transferred from northern QuebecSimulation in trauma ultrasound trainingIncidence of clinically significant intra-abdominal injuries in stable blunt trauma patientsWake up: head injury management around the clockDamage control laparotomy for combat casualties in forward surgical facilitiesDetection of soft tissue foreign bodies by nurse practitioner performed ultrasoundAntihypertensive medications and walking devices are associated with falls from standingThe transfer process: perspectives of transferring physiciansDevelopment of a rodent model for the study of abdominal compartment syndromeClinical efficacy of routine repeat head computed tomography in pediatric traumatic brain injuryEarly warning scores (EWS) in trauma: assessing the “effectiveness” of interventions by a rural ground transport service in the interior of British ColumbiaAccuracy of trauma patient transfer documentation in BCPostoperative echocardiogram after penetrating cardiac injuries: a retrospective studyLoss to follow-up in trauma studies comparing operative methods: a systematic reviewWhat matters where and to whom: a survey of experts on the Canadian pediatric trauma systemA quality initiative to enhance pain management for trauma patients: baseline attitudes of practitionersComparison of rotational thromboelastometry (ROTEM) values in massive and nonmassive transfusion patientsMild traumatic brain injury defined by GCS: Is it really mild?The CMAC videolaryngosocpe is superior to the glidescope for the intubation of trauma patients: a prospective analysisInjury patterns and outcome of urban versus suburban major traumaA cost-effective, readily accessible technique for progressive abdominal closureEvolution and impact of the use of pan-CT scan in a tertiary urban trauma centre: a 4-year auditAdditional and repeated CT scan in interfacilities trauma transfers: room for standardizationPediatric trauma in situ simulation facilitates identification and resolution of system issuesHospital code orange plan: there’s an app for thatDiaphragmatic rupture from blunt trauma: an NTDB studyEarly closure of open abdomen using component separation techniqueSurgical fixation versus nonoperative management of flail chest: a meta-analysisIntegration of intraoperative angiography as part of damage control surgery in major traumaMass casualty preparedness of regional trauma systems: recommendations for an evaluative frameworkDiagnostic peritoneal aspirate: An obsolete diagnostic modality?Blunt hollow viscus injury: the frequency and consequences of delayed diagnosis in the era of selective nonoperative managementEnding “double jeopardy:” the diagnostic impact of cardiac ultrasound and chest radiography on operative sequencing in penetrating thoracoabdominal traumaAre trauma patients with hyperfibrinolysis diagnosed by rotem salvageable?The risk of cardiac injury after penetrating thoracic trauma: Which is the better predictor, hemodynamic status or pericardial window?The online Concussion Awareness Training Toolkit for health practitioners (CATT): a new resource for recognizing, treating, and managing concussionThe prevention of concussion and brain injury in child and youth team sportsRandomized controlled trial of an early rehabilitation intervention to improve return to work Rates following road traumaPhone call follow-upPericardiocentesis in trauma: a systematic review. Can J Surg 2013. [DOI: 10.1503/cjs.005813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
26
|
Lee A, Choi S, Nguyen Q, Pugh T, Mathai B, Frank S, Hoffman K, Kuban D, McGuire S, Munsell M. Patient Quality of Life After Proton Therapy (1.8 vs 2 Gray Equivalents) for Prostate Cancer. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
27
|
Owens DA, Hoffman K, Catania T. Visual Control of Posture is Not Affected by Challenging Cognitive Tasks. J Vis 2012. [DOI: 10.1167/12.9.828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
28
|
Abbiendi G, Ainsley C, Åkesson PF, Alexander G, Anagnostou G, Anderson KJ, Asai S, Axen D, Bailey I, Barberio E, Barillari T, Barlow RJ, Batley RJ, Bechtle P, Behnke T, Bell KW, Bell PJ, Bella G, Bellerive A, Benelli G, Bethke S, Biebel O, Boeriu O, Bock P, Boutemeur M, Braibant S, Brown RM, Burckhart HJ, Campana S, Capiluppi P, Carnegie RK, Carter AA, Carter JR, Chang CY, Charlton DG, Ciocca C, Csilling A, Cuffiani M, Dado S, Dallavalle M, De Roeck A, De Wolf EA, Desch K, Dienes B, Dubbert J, Duchovni E, Duckeck G, Duerdoth IP, Etzion E, Fabbri F, Ferrari P, Fiedler F, Fleck I, Ford M, Frey A, Gagnon P, Gary JW, Geich-Gimbel C, Giacomelli G, Giacomelli P, Giunta M, Goldberg J, Gross E, Grunhaus J, Gruwé M, Gupta A, Hajdu C, Hamann M, Hanson GG, Harel A, Hauschild M, Hawkes CM, Hawkings R, Herten G, Heuer RD, Hill JC, Hoffman K, Horváth D, Igo-Kemenes P, Ishii K, Jeremie H, Jovanovic P, Junk TR, Kanzaki J, Karlen D, Kawagoe K, Kawamoto T, Keeler RK, Kellogg RG, Kennedy BW, Kluth S, Kobayashi T, Kobel M, Komamiya S, Krämer T, Krasznahorkay A, Krieger P, von Krogh J, Kuhl T, Kupper M, Lafferty GD, Landsman H, Lanske D, Lellouch D, Letts J, Levinson L, Lillich J, Lloyd SL, Loebinger FK, Lu J, Ludwig A, Ludwig J, Mader W, Marcellini S, Marchant TE, Martin AJ, Mashimo T, Mättig P, McKenna J, McPherson RA, Meijers F, Menges W, Merritt FS, Mes H, Meyer N, Michelini A, Mihara S, Mikenberg G, Miller DJ, Mohr W, Mori T, Mutter A, Nagai K, Nakamura I, Nanjo H, Neal HA, O’Neale SW, Oh A, Okpara A, Oreglia MJ, Orito S, Pahl C, Pásztor G, Pater JR, Pilcher JE, Pinfold J, Plane DE, Pooth O, Przybycień M, Quadt A, Rabbertz K, Rembser C, Renkel P, Roney JM, Rossi AM, Rozen Y, Runge K, Sachs K, Saeki T, Sarkisyan EKG, Schaile AD, Schaile O, Scharff-Hansen P, Schieck J, Schörner-Sadenius T, Schröder M, Schumacher M, Seuster R, Shears TG, Shen BC, Sherwood P, Skuja A, Smith AM, Sobie R, Söldner-Rembold S, Spano F, Stahl A, Strom D, Ströhmer R, Tarem S, Tasevsky M, Teuscher R, Thomson MA, Torrence E, Toya D, Trigger I, Trócsányi Z, Tsur E, Turner-Watson MF, Ueda I, Ujvári B, Vollmer CF, Vannerem P, Vértesi R, Verzocchi M, Voss H, Vossebeld J, Ward CP, Ward DR, Watkins PM, Watson AT, Watson NK, Wells PS, Wengler T, Wermes N, Wilson GW, Wilson JA, Wolf G, Wyatt TR, Yamashita S, Zer-Zion D, Zivkovic L. Search for charged Higgs bosons in e +e - collisions at [Formula: see text]. Eur Phys J C Part Fields 2012; 72:2076. [PMID: 25814843 PMCID: PMC4371074 DOI: 10.1140/epjc/s10052-012-2076-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/14/2008] [Revised: 06/22/2012] [Indexed: 06/04/2023]
Abstract
A search is made for charged Higgs bosons predicted by Two-Higgs-Doublet extensions of the Standard Model (2HDM) using electron-positron collision data collected by the OPAL experiment at [Formula: see text], corresponding to an integrated luminosity of approximately 600 pb-1. Charged Higgs bosons are assumed to be pair-produced and to decay into [Formula: see text], τντ or AW±. No signal is observed. Model-independent limits on the charged Higgs-boson production cross section are derived by combining these results with previous searches at lower energies. Under the assumption [Formula: see text], motivated by general 2HDM type II models, excluded areas on the [Formula: see text] plane are presented and charged Higgs bosons are excluded up to a mass of 76.3 GeV at 95 % confidence level, independent of the branching ratio BR(H±→τντ ). A scan of the 2HDM type I model parameter space is performed and limits on the Higgs-boson masses [Formula: see text] and mA are presented for different choices of tanβ.
Collapse
Affiliation(s)
- The OPAL Collaboration
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
- />Department of Physics, Indiana University, Bloomington, IN 47405 USA
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
- />University College London, London, WC1E 6BT UK
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
- />Laboratoire de Physique Nucléaire, Université de Montréal, Montréal, Québec H3C 3J7 Canada
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
- />Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire OX11 0QX UK
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
- />Department of Physics, University of British Columbia, Vancouver, BC V6T 1Z1 Canada
- />Department of Physics, University of Alberta, Edmonton, AB T6G 2J1 Canada
- />Research Institute for Particle and Nuclear Physics, 1525 Budapest, PO Box 49, Hungary
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
- />Department of Physics, Yale University, New Haven, CT 06520 USA
| | - G. Abbiendi
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - C. Ainsley
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
| | - P. F. Åkesson
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - G. Alexander
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
| | - G. Anagnostou
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - K. J. Anderson
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | - S. Asai
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - D. Axen
- />Department of Physics, University of British Columbia, Vancouver, BC V6T 1Z1 Canada
| | - I. Bailey
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
| | - E. Barberio
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - T. Barillari
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
| | - R. J. Barlow
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | | | - P. Bechtle
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - T. Behnke
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - K. W. Bell
- />Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire OX11 0QX UK
| | - P. J. Bell
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - G. Bella
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
| | - A. Bellerive
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
| | - G. Benelli
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - S. Bethke
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
| | - O. Biebel
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - O. Boeriu
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - P. Bock
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
| | - M. Boutemeur
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - S. Braibant
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - R. M. Brown
- />Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire OX11 0QX UK
| | - H. J. Burckhart
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - S. Campana
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - P. Capiluppi
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - R. K. Carnegie
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
| | - A. A. Carter
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
| | | | - C. Y. Chang
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
| | - D. G. Charlton
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - C. Ciocca
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - A. Csilling
- />Research Institute for Particle and Nuclear Physics, 1525 Budapest, PO Box 49, Hungary
| | - M. Cuffiani
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - S. Dado
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| | - M. Dallavalle
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - A. De Roeck
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - E. A. De Wolf
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - K. Desch
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - B. Dienes
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
| | - J. Dubbert
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - E. Duchovni
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - G. Duckeck
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - I. P. Duerdoth
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - E. Etzion
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
| | - F. Fabbri
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - P. Ferrari
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - F. Fiedler
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - I. Fleck
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - M. Ford
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - A. Frey
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - P. Gagnon
- />Department of Physics, Indiana University, Bloomington, IN 47405 USA
| | - J. W. Gary
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - C. Geich-Gimbel
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - G. Giacomelli
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - P. Giacomelli
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - M. Giunta
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - J. Goldberg
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| | - E. Gross
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - J. Grunhaus
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
| | - M. Gruwé
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - A. Gupta
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | - C. Hajdu
- />Research Institute for Particle and Nuclear Physics, 1525 Budapest, PO Box 49, Hungary
| | - M. Hamann
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - G. G. Hanson
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - A. Harel
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| | - M. Hauschild
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - C. M. Hawkes
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - R. Hawkings
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - G. Herten
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - R. D. Heuer
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - J. C. Hill
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
| | - K. Hoffman
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
| | - D. Horváth
- />Research Institute for Particle and Nuclear Physics, 1525 Budapest, PO Box 49, Hungary
| | - P. Igo-Kemenes
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
| | - K. Ishii
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - H. Jeremie
- />Laboratoire de Physique Nucléaire, Université de Montréal, Montréal, Québec H3C 3J7 Canada
| | - P. Jovanovic
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - T. R. Junk
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
| | - J. Kanzaki
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - D. Karlen
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
| | - K. Kawagoe
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - T. Kawamoto
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - R. K. Keeler
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
| | - R. G. Kellogg
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
| | - B. W. Kennedy
- />Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire OX11 0QX UK
| | - S. Kluth
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
| | - T. Kobayashi
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - M. Kobel
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - S. Komamiya
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - T. Krämer
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - A. Krasznahorkay
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
| | - P. Krieger
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
| | - J. von Krogh
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
| | - T. Kuhl
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - M. Kupper
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - G. D. Lafferty
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - H. Landsman
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| | - D. Lanske
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
| | - D. Lellouch
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - J. Letts
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
- />Department of Physics, Indiana University, Bloomington, IN 47405 USA
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
- />University College London, London, WC1E 6BT UK
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
- />Laboratoire de Physique Nucléaire, Université de Montréal, Montréal, Québec H3C 3J7 Canada
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
- />Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire OX11 0QX UK
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
- />Department of Physics, University of British Columbia, Vancouver, BC V6T 1Z1 Canada
- />Department of Physics, University of Alberta, Edmonton, AB T6G 2J1 Canada
- />Research Institute for Particle and Nuclear Physics, 1525 Budapest, PO Box 49, Hungary
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
- />Department of Physics, Yale University, New Haven, CT 06520 USA
| | - L. Levinson
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - J. Lillich
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - S. L. Lloyd
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
| | - F. K. Loebinger
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - J. Lu
- />Department of Physics, University of British Columbia, Vancouver, BC V6T 1Z1 Canada
| | - A. Ludwig
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - J. Ludwig
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - W. Mader
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - S. Marcellini
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - T. E. Marchant
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - A. J. Martin
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
| | - T. Mashimo
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - P. Mättig
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
- />Department of Physics, Indiana University, Bloomington, IN 47405 USA
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
- />University College London, London, WC1E 6BT UK
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
- />Laboratoire de Physique Nucléaire, Université de Montréal, Montréal, Québec H3C 3J7 Canada
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
- />Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire OX11 0QX UK
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
- />Department of Physics, University of British Columbia, Vancouver, BC V6T 1Z1 Canada
- />Department of Physics, University of Alberta, Edmonton, AB T6G 2J1 Canada
- />Research Institute for Particle and Nuclear Physics, 1525 Budapest, PO Box 49, Hungary
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
- />Department of Physics, Yale University, New Haven, CT 06520 USA
| | - J. McKenna
- />Department of Physics, University of British Columbia, Vancouver, BC V6T 1Z1 Canada
| | - R. A. McPherson
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
| | - F. Meijers
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - W. Menges
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - F. S. Merritt
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | - H. Mes
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
| | - N. Meyer
- />Institut für Experimentalphysik, Universität Hamburg/DESY, Notkestrasse 85 22607 Hamburg, Germany
| | - A. Michelini
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - S. Mihara
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - G. Mikenberg
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - D. J. Miller
- />University College London, London, WC1E 6BT UK
| | - W. Mohr
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - T. Mori
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - A. Mutter
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - K. Nagai
- />Queen Mary and Westfield College, University of London, London, E1 4NS UK
| | - I. Nakamura
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - H. Nanjo
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - H. A. Neal
- />Department of Physics, Yale University, New Haven, CT 06520 USA
| | - S. W. O’Neale
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - A. Oh
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - A. Okpara
- />Physikalisches Institut, Universität Heidelberg, 69120 Heidelberg, Germany
| | - M. J. Oreglia
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | - S. Orito
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - C. Pahl
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
| | - G. Pásztor
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - J. R. Pater
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - J. E. Pilcher
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | - J. Pinfold
- />Department of Physics, University of Alberta, Edmonton, AB T6G 2J1 Canada
| | - D. E. Plane
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - O. Pooth
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
| | - M. Przybycień
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - A. Quadt
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
| | - K. Rabbertz
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - C. Rembser
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - P. Renkel
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - J. M. Roney
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
| | - A. M. Rossi
- />Dipartimento di Fisica dell’ Università di Bologna and INFN, 40126 Bologna, Italy
| | - Y. Rozen
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| | - K. Runge
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - K. Sachs
- />Ottawa-Carleton Institute for Physics, Department of Physics, Carleton University, Ottawa, Ontario K1S 5B6 Canada
| | - T. Saeki
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - E. K. G. Sarkisyan
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - A. D. Schaile
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - O. Schaile
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - P. Scharff-Hansen
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - J. Schieck
- />Max-Planck-Institute für Physik, Föhringer Ring 6, 80805 München, Germany
| | | | - M. Schröder
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - M. Schumacher
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - R. Seuster
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
| | - T. G. Shears
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - B. C. Shen
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - P. Sherwood
- />University College London, London, WC1E 6BT UK
| | - A. Skuja
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
| | - A. M. Smith
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - R. Sobie
- />Department of Physics, University of Victoria, PO Box 3055, Victoria, BC V8W 3P6 Canada
| | - S. Söldner-Rembold
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - F. Spano
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | - A. Stahl
- />III Physikalisches Institut, Technische Hochschule Aachen, Sommerfeldstrasse 26-28, 52056 Aachen, Germany
| | - D. Strom
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
| | - R. Ströhmer
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - S. Tarem
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| | - M. Tasevsky
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - R. Teuscher
- />Enrico Fermi Institute and Department of Physics, University of Chicago, Chicago, IL 60637 USA
| | | | - E. Torrence
- />Department of Physics, University of Oregon, Eugene, OR 97403 USA
| | - D. Toya
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - I. Trigger
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - Z. Trócsányi
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
| | - E. Tsur
- />Department of Physics and Astronomy, Tel Aviv University, Tel Aviv, 69978 Israel
| | - M. F. Turner-Watson
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - I. Ueda
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - B. Ujvári
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
| | - C. F. Vollmer
- />Sektion Physik, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching, Germany
| | - P. Vannerem
- />Fakultät für Physik, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany
| | - R. Vértesi
- />Institute of Nuclear Research, 4001 Debrecen, PO Box 51, Hungary
| | - M. Verzocchi
- />Department of Physics, University of Maryland, College Park, MD 20742 USA
| | - H. Voss
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - J. Vossebeld
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - C. P. Ward
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
| | - D. R. Ward
- />Cavendish Laboratory, Cambridge, CB3 0HE UK
| | - P. M. Watkins
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - A. T. Watson
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - N. K. Watson
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - P. S. Wells
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - T. Wengler
- />CERN, European Organisation for Nuclear Research, 1211 Geneva 23, Switzerland
| | - N. Wermes
- />Physikalisches Institut, Universität Bonn, 53115 Bonn, Germany
| | - G. W. Wilson
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - J. A. Wilson
- />School of Physics and Astronomy, University of Birmingham, Birmingham, B15 2TT UK
| | - G. Wolf
- />Particle Physics Department, Weizmann Institute of Science, Rehovot, 76100 Israel
| | - T. R. Wyatt
- />School of Physics and Astronomy, Schuster Laboratory, The University of Manchester, Manchester, M13 9PL UK
| | - S. Yamashita
- />International Centre for Elementary Particle Physics and Department of Physics, University of Tokyo, Tokyo, 113-0033 Japan
- />Kobe University, Kobe, 657-8501 Japan
| | - D. Zer-Zion
- />Department of Physics and Astronomy, University of California, Riverside, CA 92521 USA
| | - L. Zivkovic
- />Department of Physics, Technion-Israel Institute of Technology, Haifa, 32000 Israel
| |
Collapse
|
29
|
Abstract
Abstract
Background
Multiple trauma is a cause of significant disability in adults of working age. Despite the implementation of trauma systems for improved coordination and organization of care, rehabilitation services are not yet routinely considered integral to trauma care processes.
Methods
MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine, Physiotherapy Evidence Database, Latin American and Caribbean Literature on Health Sciences and Cochrane Library databases were searched up to May 2011 for randomized clinical trials, as well as observational studies, reporting outcomes of injured patients following multidisciplinary rehabilitation that addressed functional restoration and societal reintegration based on the International Classification of Functioning, Disability and Health.
Results
No randomized and/or controlled clinical trials were identified. Fifteen observational studies involving 2386 participants with injuries were included. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach assessed methodological quality as ‘poor’ in all studies, with selection and observer bias. Although patients with low functional scores showed improvement after rehabilitation, they were unable to resume their pretrauma level of activity. Their functional ability was significantly associated with motor independence on admission and early acute rehabilitation, which contributed to a shorter hospital stay. Injury location, age, co-morbidity and education predicted long-term functional consequences. Trauma care systems were associated with reduced mortality. The gaps in evidence include: rehabilitation settings, components, intensity, duration and types of therapy, and long-term outcomes for survivors of multiple trauma.
Conclusion
Rehabilitation is an expensive resource and the evidence to support its justification is needed urgently. The issues in study design and research methodology in rehabilitation are challenging. Opportunities to prioritize trauma rehabilitation, disability management and social reintegration of multiple injury survivors are discussed.
Collapse
Affiliation(s)
- F Khan
- Department of Medicine, Dentistry and Health Sciences, University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia
- Department of Rehabilitation Medicine, Royal Melbourne Hospital, Melbourne, Australia
| | - B Amatya
- Department of Rehabilitation Medicine, Royal Melbourne Hospital, Melbourne, Australia
| | - K Hoffman
- Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Royal London Hospital, Whitechapel, London, UK
| |
Collapse
|
30
|
Pugh T, Frank S, Achim M, Kuban D, Lee A, Choi S, Nguyen Q, Hoffman K, McGuire S, Swanson D. Prediction of Extraprostatic Extension in Intermediate Risk Prostate Cancer: The Evolving Role of Endorectal MRI. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.642] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Nguyen Q, Crawford C, Palmer M, Zhu R, Choi S, Pugh T, Frank S, Hoffman K, Kuban D, Lee A. Utilizing A Multifield Optimization Intensity Modulated Proton Technique (MFO-IMPT) To Deliver A Simultaneous Integrated Boost (SIB) To The Dominant Intraprostatic Lesion For Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.1565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
32
|
Wang X, Zhang X, Amos R, Salehpour M, Zhang S, Sun T, Strom E, Buchholz T, Hoffman K, Woodward W. SU-E-T-776: External Beam Accelerated Partial Breast Irradiation Using Intensity Modulated Proton Therapy (IMPT). Med Phys 2011. [DOI: 10.1118/1.3612740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
33
|
Guha S, Yang J, Banerjee A, Glatfelter T, Hoffman K, Ovshinsky S, Izu M, Ovshinsky HC, Deng X. Amorphous Silicon Alloy Photovoltaic Technology - from R&D to Production. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-336-645] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
ABSTRACTThe key requirements for photovoltaic modules to be accepted for large-scale terrestrial applications are (i) low material cost, (ii) high efficiency with good stability, (iii) low manufacturing cost with good yield and (iv) environmental safety. Thin films of amorphous silicon alloy are inexpensive; the products are also environmentally benign. The challenge has been to improve the stable efficiency of these modules and transfer the R&D results into production. Using a Multijunction, Multi-bandgap approach to capture the solar spectrum more efficiently, we have developed one-square-foot modules with initial efficiency of 11.8%. After 1000 h of one-sun light soaking, a stable efficiency of 10.2% was obtained. Both the efficiency values were confirmed by National Renewable Energy Laboratory. The technology has been transferred to production using an automated roll-to-roll process in which different layers of the cell structure are deposited in a continuous manner onto stainless steel rolls, 14” wide and half a mile long. The rolls are next processed into modules of different sizes. This inexpensive manufacturing process produces high efficiency modules with subcell yields greater than 99%. The key features of the technology transfer and future scope for improvement are discussed.
Collapse
|
34
|
Müller C, Richter WD, Richter WD, Richter WD, Hoffman K, Lederer C. Book review. STATISTICS-ABINGDON 2010. [DOI: 10.1080/02331889908802647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
35
|
Patel HJ, Li J, Gonzalez-Angulo AM, Strom E, Perkins GH, Tereffe W, Yu TK, Hoffman K, Smith BD, Lucci A, Valero V, Buchholz TA, Woodward W. Abstract P1-17-02: Outcome after Locoregional Recurrence in Patients with Inflammatory Breast Cancer. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p1-17-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: High rates of locoregional recurrence (LRR) have been reported in spite of comprehensive tri-modality therapy for patients with inflammatory breast cancer (IBC). The aim of this study was to examine the prognosis of patients who have experienced LRR after treated primary IBC. Methods:
We retrospectively reviewed information for 124 IBC patients who experienced a LRR seen in our institution from 1990-2008. 63 patients had simultaneous distant disease (DM) +/−3 months of LRR (simLRR),
5 patients had LRR > 3 months subsequent to DM, while 56 patients had isolated LRR >3 months prior to DM (isLRR). Overall survival (OS) was calculated from date of recurrence using the Kaplan-Meier method. Results:
Median time to LRR from diagnosis was 13 months (interquartile range 8-21 months). Median survival after LRR was 15 months. 2-yr OS was 46%. Regarding the primary tumors, 23% were estrogen receptor positive (ER+), 33% were HER2-neu positive (H2N+), 81% had lymph vascular space invasion (LVSI), and 83% were grade 3. Comparing isLRR and simLRR cohorts, median survival was 18 months vs. 10 months and 2 yr-OS was 66% vs. 28%, respectively. ER+ and H2N+ primary status predicted for longer 2 yr OS among patients with simLRR but not among isLRR patients. (simLRR, ER+ 57% vs. ER-19% p = 0.02, H2N+ 45% vs. H2N-17% p = 0.01; IsLRR ER+ vs. ER-92% vs. 55% p = 0.15, H2N+ 86% vs. H2N-57% p = 0.11). LVSI was not prognostic in either group and Grade 3 primary trended towards worse outcome among isLRR cohort only, Grade 2 83% vs. Grade 3 64% P = 0.08. Molecular subtyping using ER and H2N status to group tumors demonstrates basal subtype in the primary tumor compared to H2N, luminal B and luminal A is associated with significantly worse 2 yr OS after isLRR (43% vs. 88%, 82%, and 83%, P = 0.04) and simLRR (13% vs. 34%, 80%, 32% P = 0.005) respectively. Conclusions:
Forty-five% of LRR occurred as isolated first events. LRRs generally occur within 2 years after primary IBC treatment and are associated with poor outcomes even as first events. Basal subtype predicts for worse overall survival regardless of distant disease.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P1-17-02.
Collapse
Affiliation(s)
- HJ Patel
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - J Li
- The University of Texas M. D. Anderson Cancer Center, Houston
| | | | - E Strom
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - GH Perkins
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - W Tereffe
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - T-K Yu
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - K Hoffman
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - BD Smith
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - A Lucci
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - V Valero
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - TA Buchholz
- The University of Texas M. D. Anderson Cancer Center, Houston
| | - W. Woodward
- The University of Texas M. D. Anderson Cancer Center, Houston
| |
Collapse
|
36
|
McGuire S, Levy L, Settle S, Choi S, Nguyen Q, Hoffman K, Frank S, Lee A, Kuban D. PSA Response to Neoadjuvant Androgen Suppression Therapy Prior to High Dose Radiotherapy Predicts Survival in Clinically Localized High Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
37
|
Morikawa L, Kudchadker R, Kanke J, Oyervides M, Frank S, Lee A, Hoffman K, Choi S, Nguyen Q, Kuban D. Endorectal Balloon in Post-operative Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.931] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
38
|
Nguyen Q, Levy L, Lee A, Choi S, Frank S, Hoffman K, McGuire S, Kuban D. Risk Factors Predicting Failure and Prostate Cancer Mortality in High Risk Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.315] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
39
|
Retter AS, Shorr R, Rodriguez R, Hoffman K, Volterra F, Hoffman AD, Huppert N, Lee K. Phase I trial of CPI-613, a lipoic acid analog, and gemcitabine in patients with advanced solid tumors. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e13136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
40
|
Mansky P, Hoffman K, Gerber L, Chrousos G, Steinberg S, Mackall C. 54 INVITED Long-term cancer survivorship issues: Is there a role for CAM? EJC Suppl 2007. [DOI: 10.1016/s1359-6349(07)70168-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
41
|
Gilsinn J, Hoffman K, Jackson RHF, Leyendecker E, Saunders P, Shier D. Methodology and analysis for comparing discrete linear l1approximation codes. COMMUN STAT-SIMUL C 2007. [DOI: 10.1080/03610917708812053] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
42
|
Dohatcu AC, Ionita CN, Sherman JR, Rangwalla HS, Bednarek DR, Hoffman K, Rudin S. SU-FF-I-128: Regional Time Density Curves (R-TDC) Derived From Angiographic Sequences for Analysis of Aneurysmal Flow Modification Resulting From Endovascular Image-Guided Interventions. Med Phys 2007. [DOI: 10.1118/1.2760504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
43
|
Hoffman K, Videan EN, Fritz J, Murphy J. Diagnosis and treatment of ocular coccidioidomycosis in a female captive chimpanzee (Pan troglodytes): a case study. Ann N Y Acad Sci 2007; 1111:404-10. [PMID: 17303834 DOI: 10.1196/annals.1406.018] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We report here the first documented case of ocular coccidioidomycosis in a chimpanzee (Pan troglodytes). In 1996, a 12-year-old female chimpanzee was undergoing treatment with an experimental triazole, BayR3783, for coccidioidomycosis when she was diagnosed with severe conjunctivitis in the right eye. Subsequent development of a coccidioidal granuloma of the ventral conjunctiva and anterior uvea was noted over the next several months, distorting the lens, iris, pupil, and sclera and progressing to uveitis. Treatment with BayR3783 and subconjunctival injections of triamcinolone were successful in reducing the ocular mass, but extensive damage was done to the lens and cornea. This case study provides an interesting comparison to ocular coccidioidomycosis cases observed in both humans and canines.
Collapse
Affiliation(s)
- K Hoffman
- Primate Foundation of Arizona, P.O. Box 20027, Mesa, AZ 85277-0027, USA
| | | | | | | |
Collapse
|
44
|
Affiliation(s)
- F. Marlow
- a Institut für Angewandte Chemie , Rudower Chaussee 5, D-12489 , Berlin
| | - J. Kornatowski
- b Institut für Brennstoffchemie, RWTH Aachen , Worringerweg 1, D-52074 , Aachen , Germany
- c Faculty of Chemistry, N. Copernicus University , Gagarina 7, 87-100 , Torun , Poland
| | - B. Reck
- d Bundesanstalt für Materialforschung und - prüfung , Rudower Chaussee 5, 12489 , Berlin , Germany
| | - I. Leike
- a Institut für Angewandte Chemie , Rudower Chaussee 5, D-12489 , Berlin
| | - K. Hoffman
- a Institut für Angewandte Chemie , Rudower Chaussee 5, D-12489 , Berlin
| | - J. Caro
- a Institut für Angewandte Chemie , Rudower Chaussee 5, D-12489 , Berlin
| |
Collapse
|
45
|
Anderson CM, Floyd J, Cunningham M, Reeder T, Hoffman K, Boren S. A randomized study of a patient narrative (storytelling) medical education process for third year medical students compared to standard clinical experience in an academic oncology practice. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - J. Floyd
- Ellis Fischel Cancer Ctr, Columbia, MO
| | | | - T. Reeder
- Ellis Fischel Cancer Ctr, Columbia, MO
| | | | - S. Boren
- Ellis Fischel Cancer Ctr, Columbia, MO
| |
Collapse
|
46
|
Abbiendi G, Ainsley C, Åkesson PF, Alexander G, Allison J, Amaral P, Anagnostou G, Anderson KJ, Asai S, Axen D, Azuelos G, Bailey I, Barberio E, Barillari T, Barlow RJ, Batley RJ, Bechtle P, Behnke T, Bell KW, Bell PJ, Bella G, Bellerive A, Benelli G, Bethke S, Biebel O, Boeriu O, Bock P, Boutemeur M, Braibant S, Brigliadori L, Brown RM, Buesser K, Burckhart HJ, Campana S, Carnegie RK, Carter AA, Carter JR, Chang CY, Charlton DG, Ciocca C, Csilling A, Cuffiani M, Dado S, De Roeck A, De Wolf EA, Desch K, Dienes B, Donkers M, Dubbert J, Duchovni E, Duckeck G, Duerdoth IP, Etzion E, Fabbri F, Feld L, Ferrari P, Fiedler F, Fleck I, Ford M, Frey A, Gagnon P, Gary JW, Gaycken G, Geich-Gimbel C, Giacomelli G, Giacomelli P, Giunta M, Goldberg J, Gross E, Grunhaus J, Gruwé M, Günther PO, Gupta A, Hajdu C, Hamann M, Hanson GG, Harel A, Hauschild M, Hawkes CM, Hawkings R, Hemingway RJ, Herten G, Heuer RD, Hill JC, Hoffman K, Horváth D, Igo-Kemenes P, Ishii K, Jeremie H, Jovanovic P, Junk TR, Kanaya N, Kanzaki J, Karlen D, Kawagoe K, Kawamoto T, Keeler RK, Kellogg RG, Kennedy BW, Kluth S, Kobayashi T, Kobel M, Komamiya S, Krämer T, Krieger P, von Krogh J, Kruger K, Kuhl T, Kupper M, Lafferty GD, Landsman H, Lanske D, Layter JG, Lellouch D, Letts J, Levinson, Lillich J, Lloyd SL, Loebinger FK, Lu J, Ludwig A, Ludwig J, Mader W, Marcellini S, Martin AJ, Masetti G, Mashimo T, Mättig P, McKenna, McPherson RA, Meijers F, Menges W, Merritt FS, Mes H, Meyer N, Michelini A, Mihara S, Mikenberg G, Miller DJ, Moed S, Mohr W, Mori T, Mutter A, Nagai K, Nakamura I, Nanjo H, Neal HA, Nisius R, O’Neale SW, Oh A, Oreglia MJ, Orito S, Pahl C, Pásztor G, Pater JR, Pilcher JE, Pinfold J, Plane DE, Poli B, Pooth O, Przybycień M, Quadt A, Rabbertz K, Rembser C, Renkel P, Roney JM, Rozen Y, Runge K, Sachs K, Saeki T, Sarkisyan EKG, Schaile AD, Schaile O, Scharff-Hansen P, Schieck J, Schörner-Sadenius T, Schröder M, Schumacher M, Scott WG, Seuster R, Shears TG, Shen B, Sherwood P, Skuja A, Smith AM, Sobie R, Söldner-Rembold S, Spano F, Stahl A, Strom D, Ströhmer R, Tarem S, Tasevsky M, Teuscher R, Thomson MA, Torrence E, Toya D, Tran P, Trigger I, Trócsányi Z, Tsur E, Turner-Watson MF, Ueda I, Ujvári B, Vollmer CF, Vannerem P, Vértesi R, Verzocchi M, Voss H, Vossebeld J, Ward CP, Ward DR, Watkins PM, Watson AT, Watson NK, Wells PS, Wengler T, Wermes N, Wilson GW, Wilson JA, Wolf G, Wyatt TR, Yamashita S, Zer-Zion D, Zivkovic L. Constraints on anomalous quartic gauge boson couplings fromνν¯γγandqq¯γγevents at CERN LEP2. Int J Clin Exp Med 2004. [DOI: 10.1103/physrevd.70.032005] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
47
|
Mansky PJ, Gerber L, Hoffman K, Augustine E, Chaudhry U, Parks B, Bernad M, Wiener L, Steinberg SM, Mackall C. Rehabilitation assessments of pediatric sarcoma survivors. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.8528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- P. J. Mansky
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - L. Gerber
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - K. Hoffman
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - E. Augustine
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - U. Chaudhry
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - B. Parks
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - M. Bernad
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - L. Wiener
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - S. M. Steinberg
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| | - C. Mackall
- NCCAM/NIH, Bethesda, MD; RMD/CC/NIH, Bethesda, MD; NCI/NIH, Bethesda, MD
| |
Collapse
|
48
|
Abbiendi G, Ainsley C, Åkesson PF, Alexander G, Allison J, Amaral P, Anagnostou G, Anderson KJ, Arcelli S, Asai S, Axen D, Azuelos G, Bailey I, Barberio E, Barillari T, Barlow RJ, Batley RJ, Bechtle P, Behnke T, Bell K, Bell P, Bella G, Bellerive A, Benelli G, Bethke S, Biebel O, Boeriu O, Bock P, Boutemeur M, Braibant S, Brigliadori L, Brown R, Buesser K, Burckhart HJ, Campana S, Carnegie R, Caron B, Carter AA, Carter JR, Chang CY, Charlton DG, Ciocca C, Csilling A, Cuffiani M, Dado S, De Roeck A, De Wolf E, Desch K, Dienes B, Donkers M, Dubbert J, Duchovni E, Duckeck G, Duerdoth IP, Etzion E, Fabbri F, Feld L, Ferrari P, Fiedler F, Fleck I, Ford M, Frey A, Fürtjes A, Gagnon P, Gary JW, Gaycken G, Geich-Gimbel C, Giacomelli G, Giacomelli P, Giunta M, Goldberg J, Gross E, Grunhaus J, Gruwé M, Günther PO, Gupta A, Hajdu C, Hamann M, Hanson GG, Harel A, Hauschild M, Hawkes CM, Hawkings R, Hemingway RJ, Hensel C, Herten G, Heuer RD, Hill JC, Hoffman K, Horváth D, Igo-Kemenes P, Ishii K, Jeremie H, Jovanovic P, Junk TR, Kanaya N, Kanzaki J, Karlen D, Kawagoe K, Kawamoto T, Keeler RK, Kellogg RG, Kennedy BW, Klein K, Klier A, Kluth S, Kobayashi T, Kobel M, Komamiya S, Kormos L, Krämer T, Krieger P, von Krogh J, Kruger K, Kuhl T, Kupper M, Lafferty GD, Landsman H, Lanske D, Layter JG, Lellouch D, Letts J, Levinson L, Lillich J, Lloyd SL, Loebinger FK, Lu J, Ludwig A, Ludwig J, Macpherson A, Mader W, Marcellini S, Martin AJ, Masetti G, Mashimo T, Mättig P, McDonald WJ, McKenna J, McMahon TJ, McPherson RA, Meijers F, Menges W, Merritt FS, Mes H, Michelini A, Mihara S, Mikenberg G, Miller DJ, Moed S, Mohr W, Mori T, Mutter A, Nagai K, Nakamura I, Nanjo H, Neal HA, Nisius R, O’Neale SW, Oh A, Okpara A, Oreglia M, Orito S, Pahl C, Pásztor G, Pater J, Pilcher JE, Pinfold J, Plane D, Poli B, Polok J, Pooth O, Przybycień M, Quadt A, Rabbertz K, Rembser C, Renkel P, Roney JM, Rosati S, Rozen Y, Runge K, Sachs K, Saeki T, Sarkisyan E, Schaile A, Schaile O, Scharff-Hansen P, Schieck J, Schörner-Sadenius T, Schröder M, Schumacher M, Schwick C, Scott WG, Seuster R, Shears TG, Shen BC, Sherwood P, Skuja A, Smith AM, Sobie R, Söldner-Rembold S, Spano F, Stahl A, Stephens K, Strom D, Ströhmer R, Tarem S, Tasevsky M, Teuscher R, Thomson MA, Torrence E, Toya D, Tran P, Trigger I, Trócsányi Z, Tsur E, Turner-Watson MF, Ueda I, Ujvári B, Vollmer C, Vannerem P, Vértesi R, Verzocchi M, Voss H, Vossebeld J, Waller D, Ward CP, Ward DR, Watkins PM, Watson AT, Watson NK, Wells PS, Wengler T, Wermes N, Wetterling D, Wilson GW, Wilson JA, Wolf G, Wyatt TR, Yamashita S, Zer-Zion D, Zivkovic L. Experimental studies of unbiased gluon jets frome+e−annihilations using the jet boost algorithm. Int J Clin Exp Med 2004. [DOI: 10.1103/physrevd.69.032002] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
49
|
Affiliation(s)
- M Hornig
- Center for Immunopathogenesis and Infectious Diseases, Dept of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
| | | | | | | |
Collapse
|
50
|
Abstract
Abstract
Tomato spotted wilt virus (TSWV) is an important plant pathogen with a wide host range, including the domesticated peanut (Arachis hypogaea L.). After initial outbreaks on peanut during the 1980s, the virus has spread to all peanut-producing states in the U.S. TSWV is transmitted by several species of thrips which are difficult to control with insecticides; therefore, control of TSWV most likely will come from selecting resistant genotypes in breeding programs. Although moderate levels of resistance have been discovered in A. hypogaea, complete virus resistance has not been found. Several Arachis species have desirable genes for plant resistances and tolerate many disease and insect pests better than the cultivated species. The objectives of this study were to (a) evaluate TSWV disease incidence and severity in accessions of Arachis species, and (b) compare levels of TSWV resistance in diploid species to selected A. hypogaea genotypes. In this study, 46 diploid Arachis spp. accessions were evaluated in the greenhouse by artificial inoculation tests for resistance to TSWV. Nine Arachis accessions were observed with no disease symptoms when TSWV isolate 10 was used as opposed to A. hypogaea lines that ranged from moderately to highly susceptible. Additional testing with more virulent isolates identified A. diogoi accession GKP 10602 and A. correntina accession GKP 9530 as highly resistant to the virus. These two accessions are being used as parents in crossing programs to incorporate TSWV resistance genes into A. hypogaea.
Collapse
Affiliation(s)
| | | | | | - K. Hoffman
- Res. Asst., Dept. of Crop Science; Prof., Dept. of Crop Science; Prof., Dept. of Plant Pathology; and Res. Assoc., Dept. of Plant Pathology, respectively; North Carolina State Univ., Raleigh, NC 27695
| |
Collapse
|